|
David L. Castaldi has been a director of the Company since 1994. He is currently an independent consultant. Mr. Castaldi was founder and Chairman of the Board (1996-2001) and Chief Executive Officer (1998-1999) of Cadent Medical Corp. a medical device company that was sold to Cardiac Science Inc. Previously Mr. Castaldi was founder and Chief Executive Officer (1987-1994) of BioSurface Technology Inc. a NASDAQ-listed biotechnology company that was sold to Genzyme Corporation. He also served as President of Baxter International�s worldwide plasma fractionation division where he was the corporate sponsor for the development of recombinant Factor VIII a biopharmaceutical with sales over $1 billion. He is a graduate of the University of Notre Dame (maxima cum laude) and Harvard Business School (with high distinction) where he was a Baker Scholar. Mr. Castaldi also serves on the Boards of Embrex Inc. | 